‘Lipidogram for a first-grade student’: screening for premature cardiovascular risk factors in children of Zabrze, Poland - Scorecard - MDSpire

‘Lipidogram for a first-grade student’: screening for premature cardiovascular risk factors in children of Zabrze, Poland

  • By

  • Krzysztof Dyrbuś

  • Beata Chodór

  • Maciej Dyrbuś

  • Zofia Mędrala

  • Karolina Konsek

  • Natalia Nafalska

  • Małgorzata Stopyra

  • Michał Krawiec

  • Dominik Bełz

  • Krzysztof Feret

  • Krystyna Czapla

  • Marzena Reguła

  • Anna Gibas

  • Alicja Chachaj

  • Przemysław Trzeciak

  • Alicja Grzanka

  • Maciej Banach

  • Piotr Przybyłowski

  • Mariusz Gąsior

  • September 23, 2025

  • 0 min

Share

Clinical Scorecard: Assessing Lipid Profiles in First-Grade Students: Early Detection of Cardiovascular Risk Factors in Children from Zabrze, Poland

At a Glance

CategoryDetail
ConditionElevated lipid levels and cardiovascular risk factors in children
Key MechanismsEarly identification of hypercholesterolaemia and overweight/obesity to prevent premature cardiovascular disease
Target PopulationFirst-grade primary school children (mostly 7-year-olds) in Zabrze, Poland
Care SettingSchool-based preventive screening with outpatient follow-up

Key Highlights

  • Approximately 15% of children had total cholesterol (TC) > 190 mg/dL, and over 50% had TC > 170 mg/dL, indicating elevated cardiovascular risk.
  • Overweight was observed in 31% of children, with obesity in 15.2%, highlighting significant prevalence of improper weight.
  • Only 17.3% of children referred for further evaluation due to high TC attended follow-up, underscoring challenges in adherence.

Guideline-Based Recommendations

Diagnosis

  • Screen first-grade children for lipid abnormalities using capillary blood total cholesterol measurement.
  • Refer children with TC > 190 mg/dL for further non-invasive outpatient evaluation including full lipid profile and cascade screening.
  • Assess blood pressure and random glycaemia; refer children with abnormal values to primary care pediatricians.

Management

  • Provide dietary recommendations for children with abnormal BMI (<18.5 or ≥25 kg/m²).
  • Refer obese children (BMI ≥ 30 kg/m²) for further evaluation of possible congenital or metabolic causes.
  • Lipid-lowering pharmacotherapy was not initiated in children with elevated LDL-C in this study, indicating conservative management.

Monitoring & Follow-up

  • Conduct follow-up evaluations for children with elevated TC to monitor lipid levels and cardiovascular risk factors.
  • Monitor adherence to dietary and lifestyle recommendations.
  • Track blood pressure and glycaemia periodically in children with abnormal initial findings.

Risks

  • Low participation rates in screening and follow-up limit early detection and intervention.
  • Non-fasting glucose measurements may limit assessment accuracy.
  • Voluntary participation may introduce selection bias affecting generalizability.

Patient & Prescribing Data

First-grade children with elevated total cholesterol in Zabrze, Poland

No lipid-lowering pharmacotherapy was initiated in children with elevated LDL-C during follow-up; management focused on lifestyle and dietary interventions.

Clinical Best Practices

  • Implement school-based universal lipid screening programs to identify children at cardiovascular risk early.
  • Ensure parental education to improve consent rates and follow-up adherence.
  • Schedule screenings at times that maximize participation and consider fasting requirements for accurate glucose and lipid assessment.
  • Use a multidisciplinary team including physicians and nurses to perform assessments.
  • Refer children with abnormal findings promptly for comprehensive evaluation and management.

References

Original Source(s)

Related Content